RNAi-Based Therapy in Experimental Ischemia-Reperfusion Injury. The New Targets

E-ISSN： 1873-4286|22|30|4651-4657

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.30, 2016-09, pp. : 4651-4657

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets

Current Pharmaceutical Design, Vol. 14, Iss. 12, 2008-04 ,pp. : 1205-1216

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy in Liver Ischemia and Reperfusion Injury

Current Pharmaceutical Design, Vol. 12, Iss. 23, 2006-08 ,pp. : 2969-2975

Bentham Science Publishers

Access to resources Recommend Favorite

RNAi-based Gene Therapy for Dominant Limb Girdle Muscular Dystrophies

Current Gene Therapy, Vol. 12, Iss. 4, 2012-01 ,pp. : 307-314

Bentham Science Publishers

Access to resources Recommend Favorite

Protective effects of ginseng total saponins against hepatic ischemia/reperfusion injury in experimental obstructive jaundice rats

By Fu Yong-qing Hua Chen Zhou Jian Cheng Bing-rong Zhang Jun

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 51, Iss. 12, 2013-12 ,pp. : 1545-1551

Informa Healthcare

Access to resources Recommend Favorite

Effect of aminoguanidine on sciatic functional index, oxidative stress, and rate of apoptosis in an experimental rat model of ischemia–reperfusion injury

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 12, 2014-01 ,pp. : 1013-1019

NRC Research Press

Access to resources Recommend Favorite